LIFECORE BIOMEDICAL, INC. DE
LIFECORE BIOMEDICAL, INC. DE
CHASKA, MN
Loading...
Price History
Market Data
| Market Cap | 180.13M |
| P/E Ratio | - |
| P/B Ratio | - |
| EPS | -1.04 |
| Dividend Yield | - |
| D/E Ratio | - |
| Current Ratio | 2.80 |
| Currency | USD |
Key Financial Metrics
135.27M
Revenue
-32.48M
Net Income
-1.04
EPS (Diluted)
-26.21M
Free Cash Flow
Profitability
Gross Margin
31.6%
Operating Margin
-6.5%
Net Profit Margin
-24.0%
EBITDA
5.32M
Returns & Efficiency
Return on Assets (ROA)
-13.8%
Return on Equity (ROE)
-
Dividend Yield
-
EPS
-1.04
Financial Health
Total Assets
235.20M
Total Debt
-
Debt to Equity
-
Current Ratio
2.80
Insider Trading
Last 12 months
0
Buys
0
Sells
0
Insiders
Quick Access Filings
10-K
Annual Report
Loading...
10-Q
Quarterly Report
Loading...
8-K
Recent News
Loading...
Company Data Library
Earnings Transcripts
Loading...
Press Releases
Loading...
Filing Sections
Loading...
Company Info
| Industry | Chemicals & Allied Products |
| HQ | CHASKA, MN |
| Fiscal Year | 2025 |
Peers
LILLY ELI & CO
LLY
894.82B
P/E: --
ELI LILLY & CO
LLY
894.82B
P/E: --
533.28B
P/E: --
ABBVIE INC.
ABBV
355.49B
P/E: --
BEIGENE, LTD.
BEIGF
306.50B
P/E: 632.4
BEONE MEDICINES LTD.
BEIGF
306.50B
P/E: 632.4
275.14B
P/E: --
MERCK & CO. INC.
MRK
275.14B
P/E: --
Quick Links
Financial Statistics
Valuation
Market Cap$180.13M
P/E Ratio (TTM)-
Price to Book-
EV/Revenue-
EV/EBITDA-
Profitability
Gross Margin31.6%
Operating Margin-6.5%
Net Margin-24.0%
ROE-
ROA-13.8%
Leverage & Liquidity
Debt to Equity-
Current Ratio2.80
Total Debt-
Total Assets$235.20M
Stockholders' Equity$-10.54M
Income Statement (FY 2025)
Revenue$135.27M
Gross Profit$42.70M
Operating Income$-8.73M
Net Income$-32.48M
EPS (Diluted)$-1.04
Cash Flow (FY 2025)
Free Cash Flow$-26.21M
Cash & Equivalents$18.86M
Revenue Growth5.0%
SEC Filings by Category
Insider Trading Activity
Neutral
0 Buys $0
0 Sales $0
0 Exercises $0
Net: $0
| Insider | Title | Date | Type | Shares | Price | Value |
|---|
Company Information
| Business Address | 3515 LYMAN BOULEVARD CHASKA, MN 55318 |
| Phone | 9523684300 |
| Incorporated | DE, US |
| EIN | 943025618 |
| Fiscal Year End | 0531 |
| Shares Outstanding | 37.40M |
| Stockholders' Equity | $-10.54M |
| Cash & Equivalents | $18.86M |
Recent Filings
View All
10-Q
Quarterly Report
Quarterly financial report with unaudited statements
Filed: 2026-05-06
Local
8-K
Current Report
Report of material events (acquisitions, earnings, executive changes)
Filed: 2026-05-06
Local
SCHEDULE 13G/A
Amended Schedule 13G
Amendment to Schedule 13G
Filed: 2026-04-27
Local
4
Insider Transaction Report
Statement of changes in beneficial ownership
Filed: 2026-04-16
Local
10-KT
Transition Annual Report
Annual report for transition period (fiscal year change)
Filed: 2026-03-16
Local
8-K
Current Report
Report of material events (acquisitions, earnings, executive changes)
Filed: 2026-03-16
Local
8-K
Current Report
Report of material events (acquisitions, earnings, executive changes)
Filed: 2026-03-05
Local
4
Insider Transaction Report
Statement of changes in beneficial ownership
Filed: 2026-03-02
Local
10-Q
Quarterly Report
Quarterly financial report with unaudited statements
Filed: 2025-11-06
Local
DEF 14A
Definitive Proxy Statement
Official proxy statement for shareholder voting
Filed: 2025-09-18
Local
10-K
Annual Report
Comprehensive annual financial report with audited statements
Filed: 2025-08-07
Local
10-Q
Quarterly Report
Quarterly financial report with unaudited statements
Filed: 2025-04-03
Local
DEF 14A
Definitive Proxy Statement
Official proxy statement for shareholder voting
Filed: 2025-02-27
Local
10-Q
Quarterly Report
Quarterly financial report with unaudited statements
Filed: 2025-01-02
Local
10-Q
Quarterly Report
Quarterly financial report with unaudited statements
Filed: 2024-10-04
Local
Loading...
Loading management data...
Loading...
Loading board of directors...
Loading...
Loading institutional holders...
Loading...
Loading short interest data...
Financial Charts Annual (10-K)
Interactive financial visualizations
Show:
Revenue & Income Trends
Revenue & Profit
Profit Margins
Balance Sheet Breakdown
Assets Composition
Capital Structure
Cash Flow Analysis
Cash Flow Components
Free Cash Flow
Growth & Performance
Revenue Growth Rate (YoY %)
Key Ratio Trends
Company Profile
General Information
| Company Name | LIFECORE BIOMEDICAL, INC. DE |
| Ticker | LFCR |
| Exchange | -- |
| Sector | Manufacturing |
| Industry | Chemicals & Allied Products |
| Headquarters | CHASKA, MN |
| Fiscal Year | 2025 |
Financial Summary
| Market Cap | 180.13M |
| Revenue | 135.27M |
| Net Income | -32.48M |
| P/E Ratio | - |
| EPS | -1.04 |
| Net Margin | -24.0% |
| ROE | - |
| Dividend Yield | - |
Insider Transactions
Loading...
My Notes & Files
Personal Notes
Attached Files
Loading...